OSTEOBLAST AND PTH/PTHRP BONE RESORPTION
成骨细胞和 PTH/PTHRP 骨吸收
基本信息
- 批准号:2079587
- 负责人:
- 金额:$ 19.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1989
- 资助国家:美国
- 起止时间:1989-08-01 至 1998-02-28
- 项目状态:已结题
- 来源:
- 关键词:biological signal transduction colony stimulating factor genetic library homeostasis hormone binding protein in situ hybridization laboratory rat molecular biology newborn animals northern blottings nuclear runoff assay nucleic acid sequence osteoblasts parathyroid hormones pathologic bone resorption receptor expression
项目摘要
The osteoblast or an osteoblast-like cell is the principal to which
parathyroid hormone (PTH) and parathyroid hormone-related protein (PTHrP)
bind in bone. We hypothesize that osteoblast-derived factors are
therefore critically important local mediators of PTH-and PTHrP-induced
bone resorption. A corollary to this hypothesis is that differences in
the actions of PTH and PTHrP on osteoblasts may help explain the
different in vivo effects of these two hormones. To pursue this
hypothesis, the effects of these two agonists on osteoblasts-derived
factors which may 1) activate mature osteoclasts or 2) stimulate
recruitment of pre-osteoclasts will be examined.
We have observed that PTH and PTHrP-treated osteoblasts release a soluble
bone-resorbing activity. This activity has been partially purified and
can directly stimulate resorption by isolated osteoclasts (under
conditions where PTHrP is inactive). This material will be purified to
homogeneity to obtain primary structural information. Amino-acid
sequence information will be used to synthesize oligonucleotide probes
for screening an Saos-2cDNA library. Based on our previous work,
demonstrating PTH-induce GM-CSF release from osteoblasts, this molecule
will be studied as an example of an osteoblast-derived factor which may
regulate osteoclast recruitment. The molecular mechanisms underlying
PTH/PTHrP-stimulated release of GM-CSF from osteoclast will be examining
the effects of neutralizing antisera to GM-CSF on PTH/PTHrP-induced
resorption in the fetal rat long-bone and mouse metatarsal assays.
We have very recently identified CSF-1 receptors (c-fms) in mature rat
osteoclasts. Further, in preliminary studies we have identified down-
regulation of this receptor by GM-CSF suggesting an important interaction
between these two colony-stimulating factors in regulating osteoclast
biology. These observations will be pursued using immunocytochemical
techniques and in situ hybridization. Specifically, we will study
whether the effect of GM-CSF on c-fms occurs at the level of
transcription or translation.
Finally, a mammalian expression system employing rat insulinoma cells has
been developed using the three available cDNA clones for PTHrP. The
effects of amino-terminal purified recombinant PTHrP on signal
transduction mechanisms in, and release of resorptive cytokines from,
osteoblasts will be studied. In the aggregate, these studies should
allow a more precise picture of the cellular mechanisms by which PTH and
PTHrP induce resorption in bone and should lead to a clearer picture of
how these compounds act under physiologic conditions as well as those of
disturbed mineral homeostasis.
成骨细胞或成骨细胞样细胞是主要的,
甲状旁腺激素(PTH)和甲状旁腺相关蛋白(PTHrP)
在骨头上绑起来。 我们假设成骨细胞衍生因子是
因此,PTH和PTHrP诱导的
骨吸收 这一假设的一个推论是,
PTH和PTHrP对成骨细胞的作用可能有助于解释
这两种激素在体内的不同作用。 追求这个
假设,这两种激动剂对成骨细胞衍生的
可能1)激活成熟破骨细胞或2)刺激
将检查前破骨细胞的募集。
我们已经观察到PTH和PTHrP处理的成骨细胞释放可溶性
骨吸收活性。 该活性已被部分纯化,
可以直接刺激分离的破骨细胞的吸收(在
PTHrP失活的条件)。 这些材料将被纯化,
同质性以获得初级结构信息。 氨基酸
序列信息将用于合成寡核苷酸探针
筛选Saos-2cDNA文库。 基于我们之前的工作,
证明PTH诱导GM-CSF从成骨细胞释放,这种分子
将作为成骨细胞衍生因子的一个例子进行研究,
调节破骨细胞募集。 的分子机制
将检查PTH/PTHrP刺激的破骨细胞释放GM-CSF
GM-CSF中和抗血清对PTH/PTHrP诱导的
胎鼠长骨和小鼠跖骨测定中的吸收。
我们最近在成年大鼠中鉴定了CSF-1受体(c-fms),
破骨细胞 此外,在初步研究中,我们已经确定下来-
GM-CSF对该受体的调节表明了重要的相互作用
这两种集落刺激因子在调节破骨细胞中的作用
生物学 这些观察结果将采用免疫细胞化学
技术和原位杂交。 具体来说,我们将研究
GM-CSF对c-fms的影响是否发生在水平
转录或翻译。
最后,使用大鼠胰岛素瘤细胞的哺乳动物表达系统具有
使用PTHrP的三个可用cDNA克隆开发。 的
氨基端纯化的重组PTHrP对信号的影响
再吸收性细胞因子的转导机制和释放,
将研究成骨细胞。 总体而言,这些研究应
允许更精确地了解PTH和
PTHrP诱导骨吸收,并应导致更清晰的图片,
这些化合物如何在生理条件下起作用,以及
矿物质平衡紊乱
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KARL Leonard INSOGNA其他文献
KARL Leonard INSOGNA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KARL Leonard INSOGNA', 18)}}的其他基金
Different Roles for Colony Stimulating Factor 1 Isoforms in Anabolic Therapy for Low Bone Mass
集落刺激因子 1 同工型在低骨量合成代谢治疗中的不同作用
- 批准号:
10585240 - 财政年份:2023
- 资助金额:
$ 19.9万 - 项目类别:
An ounce of prevention: stopping menopausal bone loss before it starts
一盎司的预防:在更年期骨质流失开始之前阻止它
- 批准号:
10324591 - 财政年份:2021
- 资助金额:
$ 19.9万 - 项目类别:
The Role of Sphingosine Kinases in Bone Anabolism
鞘氨醇激酶在骨合成代谢中的作用
- 批准号:
9274156 - 财政年份:2016
- 资助金额:
$ 19.9万 - 项目类别:
A novel SATB2 mutation illuminates bone anabolism
一种新的 SATB2 突变阐明了骨合成代谢
- 批准号:
8874913 - 财政年份:2014
- 资助金额:
$ 19.9万 - 项目类别:
A novel SATB2 mutation illuminates bone anabolism
一种新的 SATB2 突变阐明了骨合成代谢
- 批准号:
8758799 - 财政年份:2014
- 资助金额:
$ 19.9万 - 项目类别:
Calcitonin for Treating X-linked Hypophosphatemia
降钙素治疗 X 连锁低磷血症
- 批准号:
8319251 - 财政年份:2011
- 资助金额:
$ 19.9万 - 项目类别:
Calcitonin for treating X-linked hypophosphatemia
降钙素治疗 X 连锁低磷血症
- 批准号:
8193343 - 财政年份:2011
- 资助金额:
$ 19.9万 - 项目类别:
Conditional Deletion of PTHrP in Articular Chondrocytes
关节软骨细胞中 PTHrP 的条件性缺失
- 批准号:
7609121 - 财政年份:2008
- 资助金额:
$ 19.9万 - 项目类别:
Conditional Deletion of PTHrP in Articular Chondrocytes
关节软骨细胞中 PTHrP 的条件性缺失
- 批准号:
7509044 - 财政年份:2007
- 资助金额:
$ 19.9万 - 项目类别:
Microcomputed tomography device (Scanco microCT35)
微型计算机断层扫描设备(Scanco microCT35)
- 批准号:
7389328 - 财政年份:2007
- 资助金额:
$ 19.9万 - 项目类别:
相似海外基金
Different Roles for Colony Stimulating Factor 1 Isoforms in Anabolic Therapy for Low Bone Mass
集落刺激因子 1 同工型在低骨量合成代谢治疗中的不同作用
- 批准号:
10585240 - 财政年份:2023
- 资助金额:
$ 19.9万 - 项目类别:
SBIR Phase II: Development Of An Orally Administered Gene Therapy For Granulocyte Colony-Stimulating Factor
SBIR II 期:开发粒细胞集落刺激因子口服基因疗法
- 批准号:
2133290 - 财政年份:2022
- 资助金额:
$ 19.9万 - 项目类别:
Cooperative Agreement
Blockade of colony stimulating factor 1 receptor to reduce inflammatory nerve injury
阻断集落刺激因子 1 受体以减少炎症神经损伤
- 批准号:
10195632 - 财政年份:2021
- 资助金额:
$ 19.9万 - 项目类别:
F-18 labelled PET tracer for imaging macrophage colony stimulating factor 1 receptor (CSF1R) in neuroinflammation
F-18 标记的 PET 示踪剂,用于神经炎症中巨噬细胞集落刺激因子 1 受体 (CSF1R) 的成像
- 批准号:
9912886 - 财政年份:2020
- 资助金额:
$ 19.9万 - 项目类别:
F-18 labelled PET tracer for imaging macrophage colony stimulating factor 1 receptor (CSF1R) in neuroinflammation
F-18 标记的 PET 示踪剂,用于神经炎症中巨噬细胞集落刺激因子 1 受体 (CSF1R) 的成像
- 批准号:
10260389 - 财政年份:2020
- 资助金额:
$ 19.9万 - 项目类别:
Expanded Clinical Trial of Granulocyte Colony-Stimulating Factor (G-CSF) to Treat Hot Flush and Other Vasomotor Symptoms in Women with Naturally-Occurring and Surgically-Induced Menopause
粒细胞集落刺激因子 (G-CSF) 治疗自然发生和手术引起的更年期女性潮热和其他血管舒缩症状的扩大临床试验
- 批准号:
9907820 - 财政年份:2020
- 资助金额:
$ 19.9万 - 项目类别:
Granulocyte macrophage colony stimulating factor regulation of macrophage functions
粒细胞巨噬细胞集落刺激因子调节巨噬细胞功能
- 批准号:
551190-2020 - 财政年份:2020
- 资助金额:
$ 19.9万 - 项目类别:
University Undergraduate Student Research Awards
F-18 labelled PET tracer for imaging macrophage colony stimulating factor 1 receptor (CSF1R) in neuroinflammation
F-18 标记的 PET 示踪剂,用于神经炎症中巨噬细胞集落刺激因子 1 受体 (CSF1R) 的成像
- 批准号:
10390394 - 财政年份:2020
- 资助金额:
$ 19.9万 - 项目类别:
Role of colony stimulating factor 1 receptor (CSF1R) in graft vascular disease
集落刺激因子 1 受体 (CSF1R) 在移植血管疾病中的作用
- 批准号:
9755232 - 财政年份:2018
- 资助金额:
$ 19.9万 - 项目类别:
Role of colony stimulating factor 1 receptor (CSF1R) in graft vascular disease
集落刺激因子 1 受体 (CSF1R) 在移植血管疾病中的作用
- 批准号:
9611843 - 财政年份:2018
- 资助金额:
$ 19.9万 - 项目类别: